{"id":9150,"date":"2018-05-17T07:45:00","date_gmt":"2018-05-17T05:45:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/"},"modified":"2018-05-17T07:45:00","modified_gmt":"2018-05-17T05:45:00","slug":"irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/","title":{"rendered":"IRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista"},"content":{"rendered":"

[mfn_before_post]<\/p>\n

IRLAB Therapeutics AB:s styrelse har beslutat att utv\u00e4rdera f\u00f6ruts\u00e4ttningarna f\u00f6r att notera bolagets aktie p\u00e5 Nasdaq Stockholms huvudlista.<\/strong><\/div>\n
IRLAB:s aktier handlas sedan den 28 februari 2017 p\u00e5 Nasdaq Stockholm First North Premier. Styrelsen bed\u00f6mer att en notering p\u00e5 huvudlistan f\u00f6rb\u00e4ttrar bolagets m\u00f6jligheter att utvecklas.<\/p><\/pre>\n
\n
F\u00f6r vidare information<\/strong><\/p>\n
Nicholas Waters, VD\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
Tel: +46 730 75 77 01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0\u00a0
E-post: nicholas.waters@irlab.se<\/a><\/p>\n
Viktor Siewertz, CFO\u00a0
Tel: +46 727 10 70 70\u00a0
E-post: viktor.siewertz@irlab.se<\/a><\/p>\n
Denna information \u00e4r s\u00e5dan information som IRLAB Therapeutics AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersoners f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 17 maj 2018 kl. 07:45 CET.<\/p>\n
FNCA Sweden AB \u00e4r Bolagets Certified Adviser p\u00e5 Nasdaq First North Premier.<\/p>\n<\/div>\n
\n
Om IRLAB<\/strong><\/p>\n
IRLAB \u00e4r ett forsknings- och utvecklingsbolag, listat p\u00e5 Nasdaq First North Premier som fokuserar p\u00e5 utveckling av nya l\u00e4kemedel f\u00f6r behandling av neurodegenerativa sjukdomar, i synnerhet Parkinsons sjukdom och demens.<\/p>\n
IRLAB har tv\u00e5 kliniska l\u00e4kemedelskandidater, IRL752 och IRL790, inriktade mot medicinska behov vid Parkinsons sjukdom, samt ytterligare projekt i preklinisk fas.<\/p>\n
IRLAB:s forskning syftar till att uppt\u00e4cka och utveckla nya l\u00e4kemedelskandidater f\u00f6r behandling av hj\u00e4rnans sjukdomar, d\u00e4r stora medicinska behov idag f\u00f6religger. Med hj\u00e4lp av den unika systembiologiska forskningsplattformen, ISP, uppt\u00e4cks dess nya behandlingsprinciper.<\/p>\n
IRLAB \u00e4r baserat i G\u00f6teborg. IRLAB:s verksamhet bedrivs huvudsakligen genom dotterbolaget Integrative Research Laboratories Sweden AB.<\/p>\n
F\u00f6r mer information, v\u00e4nligen bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n
[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"
IRLAB Therapeutics AB:s styrelse har beslutat att utv\u00e4rdera f\u00f6ruts\u00e4ttningarna f\u00f6r att notera bolagets aktie p\u00e5 Nasdaq Stockholms huvudlista.<\/p>\n","protected":false},"template":"","class_list":["post-9150","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ca_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-lhfi_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ca-other_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB Therapeutics AB:s styrelse har beslutat att utv\u00e4rdera f\u00f6ruts\u00e4ttningarna f\u00f6r att notera bolagets aktie p\u00e5 Nasdaq Stockholms huvudlista.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/\",\"name\":\"IRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2018-05-17T05:45:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB","og_description":"IRLAB Therapeutics AB:s styrelse har beslutat att utv\u00e4rdera f\u00f6ruts\u00e4ttningarna f\u00f6r att notera bolagets aktie p\u00e5 Nasdaq Stockholms huvudlista.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/","name":"IRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2018-05-17T05:45:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-forbereder-notering-pa-nasdaq-stockholms-huvudlista\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB f\u00f6rbereder notering p\u00e5 Nasdaq Stockholms huvudlista"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}